EN
登录

IBN和BioMedWire被任命为2023年10月BioPharma Nexus活动的官方媒体合作伙伴

IBN and BioMedWire Named Official Media Partners for BioPharma Nexus Events in October 2023

GlobeNewswire 等信源发布 2023-10-09 21:35

可切换为仅中文


LOS ANGELES, Oct. 09, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork ('IBN'), a dynamic communications organization, is delighted to announce its collaboration with BioPharma Nexus as an official media partner for its events this month. Additionally, BioMedWire, a specialized communications platform dedicated to the life sciences sector and a key part of IBN’s Dynamic Brand Portfolio (DBP), will also serve as an official media partner for the forthcoming events.

洛杉矶,2023年10月9日(GLOBE NEWSWIRE)-通过InvestorWire-动态通信组织InvestorBrandNetwork('IBN')很高兴宣布与BioPharma Nexus合作作为其活动的官方媒体合作伙伴本月。此外,BioMedWire是一个致力于生命科学领域的专业通信平台,也是IBN动态品牌组合(DBP)的关键部分,也将成为即将举行的活动的官方媒体合作伙伴。

BioPharma Nexus is a distinguished conference company with a primary focus on facilitating connections among pharmaceutical and biotechnology companies, as well as service providers. Leveraging its expertise in the life sciences industry, BioPharma Nexus organizes industry-leading events spanning clinical trials, drug discovery, medical affairs, pharmaceutical supply chains and related logistics.

BioPharma Nexus是一家杰出的会议公司,主要致力于促进制药和生物技术公司以及服务提供商之间的联系。BioPharma Nexus利用其在生命科学行业的专业知识,组织跨临床试验,药物发现,医疗事务,制药供应链和相关物流等行业领先的活动。

BioPharma Nexus' highly skilled team customizes conferences to optimize productivity and enhance global networking opportunities, rendering these events essential for industry professionals. BioPharma Nexus' market research, tailored to address attendee pain points and unlock collaborative opportunities, ensures that its events deliver world-class professional and educational experiences.

BioPharma Nexus的高技能团队定制会议,以优化生产力并增强全球联网机会,使这些活动对行业专业人员至关重要。BioPharma Nexus的市场研究旨在解决与会者的痛苦点并释放合作机会,确保其活动提供一流的专业和教育经验。

With an extensive portfolio encompassing both virtual and live formats, BioPharma Nexus stands as a global leader in these specialized domains. IBN and BioMedWire will collaborate with BioPharma Nexus on the following events: • 18th BioPharma Clinical Trials Nexus (Philadelphia, October 17-18, 2023) • 18th BioPharma Medical Affairs Nexus (Philadelphia, October 17-18, 2023) • 18th BioPharma Drug Discovery Nexus (Philadelphia, October 17-18, 2023) • 2nd BioPharma Supply Chain and Logistics Nexus (Philadelphia, Octobe.

BioPharma Nexus拥有涵盖虚拟和实时格式的广泛投资组合,在这些专业领域担任全球领导者。IBN和BioMedWire将在以下活动中与生物制药关系合作:•第18个生物制药临床试验关系(费城,2023年10月17日至18日)•第18个生物制药医疗事务关系(费城,2023年10月17日至18日)•第18个生物制药药物发现关系(费城,2023年10月17日至18日)•第二个生物制药供应链和物流关系(费城,Octobe)。